Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination

Int J Infect Dis. 2022 Jan:114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.

Authors

Sun Hye Shin¹, Jun Ki Hong¹, Soon Auck Hong², Kapsok Li¹, Kwang Ho Yoo³

Affiliations

¹ Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
² Department of Pathology, Chung-Ang University College of Medicine, Seoul, Korea.
³ Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea. Electronic address: psyfan9077@naver.com.

No abstract available

Keywords: COVID-19; Pityriasis rosea; Vaccination; mRNA-1273.

MeSH terms

2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines
COVID-19*
Humans
Pityriasis Rosea* / diagnosis
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273